Over the last few years, the convergence of life sciences companies and traditional real property developers has led to the emergence of an alternative real estate asset class known increasingly as “propsci.” While this is...more
9/23/2020
/ Asset Management ,
Capital Investments ,
Change of Control ,
Exclusivity ,
Exit Strategies ,
Investors ,
Joint Venture ,
Land Developers ,
Life Sciences ,
Operators ,
Partnership Agreements ,
Public Private Partnerships (P3s) ,
Real Estate Investments ,
Remedies ,
Transfer of Assets
The COVID-19 pandemic is disrupting the world's economy in ways that were unimaginable a few weeks ago. Will this disruption excuse you or your counterparty's contractual rights and obligations under real estate related...more